The Jordan Company, a New York-based middle-market buyout firm, has closed its second fund with $3.6 billion in capital commitments. It already has invested around 15% of the fund in four companies, including one in
Limited partners include CalSTRS, CPP Investment Board, New Jersey Investment Board, Irish National Pensions Reserves Fund, Illinois State Board of Investment, New York State Teachers Retirement System and TIAA-CREF.
The Jordan Company LP, a leading middle market private equity firm with a 30-year history of investing in partnership with management, today announced the final closing of its second private equity fund with commitments totaling $3.6 billion.
Called The Resolute Fund II, L.P., the fund is managed by six managing principals who have been investing together at The Jordan Company for more than 17 years, including John (“Jay”) Jordan II, Jonathan (“Jeb”) Boucher, A. Richard Caputo, Adam Max, Thomas Quinn and David Zalaznick. They are joined by a team of investment professionals and operating executives in the firm's Operations Management Group. The firm is headquartered in New York and has offices in Chicago, Beijing and Shanghai.
“We are very pleased to have completed a successful fundraising above our original target,” said Jordan. “We have amassed a very strong and internationally diverse group of institutional Limited Partners who understand our value-added investment approach, and appreciate the hands-on operational expertise we employ to enhance the growth of our portfolio companies. We are thankful for their continued confidence and support.”
Fund investors include, CalSTRS, CPP Investment Board, New Jersey Investment Board, Irish National Pensions Reserves Fund, Illinois State Board of Investment, New York State Teachers Retirement System and TIAA-CREF.
Four investments have been completed in The Jordan Company's Resolute Fund II between the first and final closings. The new investments are:
* Harrington Holdings, a leading marketer and distributor of healthcare products;
* Production Resource Group, the world's largest independent provider of lighting equipment and services to the premier live event industry, operating as a single-source provider of technology solutions;
* Omnimedia, an integrated TV advertising and other advertising media company located in China, and;
* Worldwide Clinical Trials, a global Contract Research Organization that provides early and late stage drug development services.
The Jordan Company received legal advice from Mayer Brown LLP, and Credit Suisse acted as placement agent in connection with the fundraising.
About The Jordan Company LP
The Jordan Company (www.thejordancompany.com) is a leading middle-market private equity firm that has maintained a consistent investment strategy and established a successful track record of acquiring and growing companies in partnership with management. Founded in 1982, the firm has a strong heritage and mature culture resulting from a history of more than 90 platform investments and over 300 add-on acquisitions across a variety of industries, including industrial products and services, healthcare, consumer/retail and financial services. The Jordan Company currently manages over $5 billion of assets, and generates proprietary deal flow through a well-developed network of sourcing relationships.
Investing through its Resolute Funds I and II, the firm has made investments in such companies as The Techs, Precision Engineered Products, International Mining and Machinery, Sensus Metering Systems, TAL International, Haas TCM, Harrington Holdings, Production Resource Group and Worldwide Clinical Trials. Headquartered in New York, The Jordan Company has offices in Chicago, Beijing and Shanghai.